Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Cutaneous Lymphoma or Not?: Exploring CD8+ T-cell skin infiltrates
Description
Dr. Joan Guy Tart presents insights from her clinic on differentiating cutaneous T-cell lymphomas, particularly focusing on CD8+ T-cell infiltrates. She emphasizes the importance of accurate diagnosis, noting that many cases initially thought to be lymphoma are instead reactive processes. The distinctions between CD4 and CD8 T-cells are addressed, highlighting their different responses to antigens and the complexity of identifying the aggression level of various lymphomas. Tart shares several clinical cases involving atypical CD8+ T-cell clones that mimic lymphomas but represent different underlying issues, including immune dysregulation and viral infections. The discussion includes the need for thorough investigations, such as genetic mutation checks and evaluating patients for potential underlying conditions leading to chronic immune issues. She concludes by underscoring that these CD8+ infiltrates often do not signify true lymphomas and emphasizes the necessity for careful phenotype assessments to ensure accurate treatment and prognosis for patients.
View moreConclusions
- Clonal expansions of CD8 positive cutaneous T-cell infiltrates are often atypical and worrisome, but do not qualify as lymphomas.
- The distinction between CD4+ and CD8+ T-cell phenotypes in cutaneous T-cell lymphomas (CTCL) is complex and warrants further exploration.
- Conditions like lymphomatoid papulosis may have immunophenotypes of largely unknown significance.
- Evolving concepts around diseases like Sézary syndrome are being challenged, particularly regarding their classification based on CD4+ versus CD8+ expression.
- Many CD8+ T-cell expansions are associated with immune dysregulation and germline mutations, rather than malignancy.
- Common lymphoma driving mutations are often absent in these atypical cases of CD8+ T-cell expansions.
- Thanks to new insights into immune responses and genetic mutations, accurate diagnosis and treatment plans can be tailored for patients presenting with these conditions.
- Cao S, et al. CD8+ T lymphocytes in hypopigmented MF: malignant cells or reactive clone? JID 2023.
- Martinez-Escala ME, Kantor RW, Cices A, Zhou XA, Kaplan JB, Pro B, Choi J, Guitart J. CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder. JAAD Sep 2017.
- Luque-Luna M et al. JAMA Dermatology 2021.
- Hile A. JAAD 2020.
- SH2023-76. Spontaneously regressing clonal y8 T-cell lymphoma proliferation in subcutaneous fat of a patient with RIPK1 mutation: indolent primary cutaneous y8 T-cell lymphoma, an autoinflammatory associated proliferation of y8 T-cells, or a bit of both?
- Valera ET, Garrigue A, Kelso S, Sicheri F, Mikael LG, Hamel N, et al. Germline HAVCR2 mutations abrogates TIM-3 membrane expression leading to persistent immune activation and cytokine production characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. Nature Genetics, Dec 2018.
- Bunworasate U, Pirunsarn A, Wudhikarn K, Lawasut P, Uaprasert N et al. Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma. Nature Genetics, Feb 2019.
- Guitart J, Mangold AR, Martinez-Escala ME, Walker CJ, Comfere NI, Pulitzer M, Rieger KE, Torres-Cabala CA, Pincus LB, Kumar ES, Wang E, Park KE, Espinosa ML, Duvic M, Kim YH, Horwitz S. JAMA Dermatology. Oct 2022.